Abstract
Salmeterol + fluticasone combination in a single inhaler was introduced to the asthma treatment 20 years ago. Since then, it possess the prominent place in asthma and COPD treatment guidelines. Due to safety and efficacy it belongs to first choice asthma treatment from step 3 through 5 in GINA 2019 guidelines. It reduces airway hyperreactivity and increases the number of asthma free-days and the number of days without rescue medication.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call